Loading...
NPI 1962463786 · Las Vegas, NV · Clinical Medical Laboratory
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Laboratory Medicine Consultants Ltd is a clinical medical laboratory provider located in Las Vegas, Nevada. This profile covers 49 Medicare and 162 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Laboratory Medicine Consultants Ltd |
| Address | 7455 W Washington Ave |
| City | Las Vegas |
| State | NV |
| ZIP | 89128 |
| Taxonomy | Clinical Medical Laboratory |
| NPI Enumerated | March 31, 2006 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicaid | $9.2M |
| Medicare | $1.9M |
This provider’s payer mix is heavily weighted toward Medicaid: total Medicaid revenue is $9.2M compared with total Medicare revenue of $1.9M, making Medicaid the dominant payer by scale for this entity. The relative sizes suggest the lab’s business is largely driven by state-contracted or volume-based Medicaid testing rather than Medicare fee-for-service work.
Medicare revenue is highly concentrated: the precomputed top-3 Medicare codes account for 73.7% of Medicare revenue, and a single code, 88305, represents $1.3M or 65.6% of the provider’s Medicare receipts. That concentration indicates the Medicare book is primarily surgical pathology interpretation rather than a broad mix of routine laboratory panels.
The provider’s code mix reflects a pathology- and anatomic-lab–centric operation: high Medicare volumes for 88305, G0416, and multiple immunohistochemistry/in situ hybridization codes (88341, 88342, 88344, 88360, 88368) plus cytopathology codes (88173, 88112) show both technical slide-processing and pathologist interpretive services are core offerings. This pattern is consistent with a clinical medical laboratory that provides both technical testing and professional pathology reads, including specialized tissue and molecular preparatory work.
Medicaid billing shows substantial high-volume clinical and molecular testing in addition to pathology: the top Medicaid codes include 88305 ($1.5M), 80307 ($803.7K), 85027 ($592.7K), and 80053 ($511.2K), and the precomputed top-3 Medicaid codes account for 41.0% of Medicaid revenue. Large claim counts for common chemistry and infectious disease NAAT codes (e.g., 87491, 87591, 87624) plus a sizeable 80307 presumptive drug-testing line point to high-throughput, routine diagnostic services consistent with a reference-lab footprint and broad specimen intake.
Competitive standing on key pathology codes is outsized nationally for specific services: Medicare 88305 ranks #46 of 14580 providers nationally (100th percentile; extreme outlier), and 88173 ranks #13 of 4276 (100th percentile; notably above typical national volume). Those national rankings indicate the provider is a major national outlier on select surgical pathology and cytopathology procedures despite a modest overall Medicare revenue base.
Within Nevada Medicaid, the provider is a clear high-volume performer on many assays: 88305 is #2 of 94 in-state (99th percentile; extreme outlier), 88312 is #1 of 35 in-state (100th percentile; extreme outlier), and several routine chemistry and panel codes (e.g., 85027, 80048, 80053, 83605) rank in the top few statewide. These state-level placements point to a dominant laboratory presence in Nevada for both anatomic pathology and high-throughput clinical testing, consistent with sizable in-state market share or major contract relationships.
Several individual codes are statistical outliers that signal specialty capability beyond routine panels: nationally flagged “extreme outlier” or “notably above typical” statuses for codes such as 88305 (national extreme outlier), 88363 (rank #3 nationally; extreme outlier), and high-percentile placements for multiple IHC/ISH codes indicate the lab performs specialized tissue selection and advanced stain/interpretation workflows at volumes well above peers. These outlier positions suggest the lab supports complex pathology and molecular downstream testing workflows.
The NPI was enumerated on 2006-03-31 (~20 years ago), indicating long tenure in the market. That sustained presence aligns with the scale and range of services observed across both Medicare and Medicaid billing and supports the interpretation that these high volumes reflect established operational capacity and payer relationships rather than a recent ramp-up.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
49 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 88305 | The physician, typically a pathologist, performs a level IV examination of a surgical pathology specimen. The examination includes accessioning the specimen into the lab, which involves formally… | 27,250 | $50 | $1.3M |
| 88341 | The lab analyst applies an additional single antibody stain on a slide or slides prepared from the same patient specimen as the initial antibody stain, such as tumor tissue. Then a qualified… | 1,220 | $70 | $79.4K |
| 88173 | The lab analyst performs the technical lab test to analyze a cytopathology specimen from a fine needle aspirate and then interprets and reports the results. | 600 | $130 | $75.1K |
| G0416 | Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | 370 | $200 | $71.6K |
| 88342 | The lab analyst applies an initial single antibody stain on a slide or slides prepared from a single patient specimen, such as tumor tissue. Then a qualified provider, typically a pathologist,… | 960 | $70 | $62.2K |
| 88360 | The lab analyst applies a single antibody stain on a slide or slides prepared from a single patient specimen, such as tumor tissue. Then a qualified provider, typically a pathologist, evaluates the… | 610 | $90 | $56.6K |
| 88344 | The lab analyst applies a single multiplex antibody stain on a slide or slides prepared from a single patient specimen, such as tumor tissue. Then a qualified provider, typically a pathologist,… | 410 | $130 | $53.5K |
| 88312 | The lab analyst performs the technical lab steps to stain a specimen with a special stain. This code applies to Group I for microorganisms. A qualified provider, typically a pathologist, interprets… | 410 | $80 | $33.2K |
| G0145 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under… | 1,100 | $30 | $28.5K |
| 88120 | The lab analyst performs a technical lab test on a urinary tract specimen using in situ hybridization and three to five molecular probes for manual morphometric analysis, looking at the number and… | 50 | $470 | $22.7K |
Showing 1–10 of 49
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 49 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
162 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 88305 | The physician, typically a pathologist, performs a level IV examination of a surgical pathology specimen. The examination includes accessioning the specimen into the lab, which involves formally… | 57,140 | $30 | $1.5M |
| 80307 | The lab analyst performs presumptive drug test(s) via instrumented chemistry analyzers to screen for any number of drug classes on a single date. | 22,960 | $40 | $803.7K |
| 85027 | The lab analyst performs a blood count on the red and white blood cells and platelets also known as thrombocytes. He also determines the hemoglobin, typically by spectrophotometry, and the… | 148,170 | $1 | $592.7K |
| 80053 | The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel. | 85,210 | $10 | $511.2K |
| 87150 | The lab analyst performs an analysis using amplified DNA or RNA probe technique on a previously isolated and identified organism to categorize the organism more specifically, such as to the taxonomic… | 950 | $410 | $388.8K |
| 87491 | The lab analyst performs a test for Chlamydia trachomatis using amplified nucleic acid probe technique. | 28,460 | $10 | $284.6K |
| 87591 | The lab analyst performs a lab test for Neisseria gonorrhoeae, also called GC, using amplified nucleic acid probe technique. | 28,390 | $10 | $283.9K |
| 87798 | The lab analyst performs a test for an infectious agent not specified in another code using an amplified nucleic acid probe technique. Use this code if you know the laboratory technique is amplified… | 8,910 | $30 | $258.4K |
| 80048 | The lab analyst performs a basic metabolic pane (BMP) test in which he measures the blood level of eight chemicals including total calcium, sodium, potassium, chloride, carbon dioxide, glucose, blood… | 57,580 | $1 | $230.3K |
| 87624 | The lab analyst performs a test to determine the presence of human papillomavirus, or HPV. The provider uses nucleic acid detection for high–risk types and produces a pooled result. | 17,870 | $10 | $196.6K |
Showing 1–10 of 162
How this provider's Medicaid billing volume and revenue compare to other Nevada providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Nevada median
162 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high… | 22 | 60 | 680 | $60 | $364.3K |
| 87798 | The lab analyst performs a test for an infectious agent not specified in another code using an amplified nucleic acid probe technique. Use this code if you know the laboratory technique is amplified… | 3 | 30 | 290 | $60 | $260.3K |
| 80307 | The lab analyst performs presumptive drug test(s) via instrumented chemistry analyzers to screen for any number of drug classes on a single date. | 15 | 150 | 1,440 | $20 | $193.7K |
| 88175 | The lab analyst performs the technical lab test to analyze a cervical or vaginal cytopathology specimen that a clinician collected in preservative fluid. The test uses automated thin layer… | 2 | 10 | 5,040 | $10 | $149.8K |
| 87624 | The lab analyst performs a test to determine the presence of human papillomavirus, or HPV. The provider uses nucleic acid detection for high–risk types and produces a pooled result. | 2 | 10 | 2,380 | $10 | $134.6K |
| 81513 | The lab analyst performs the technical lab test on a vaginal fluid specimen for quantitative real–time amplification of RNA markers for three bacterial species listed in the code descriptor, and… | 2 | 10 | 4,510 | $10 | $118.1K |
| 87150 | The lab analyst performs an analysis using amplified DNA or RNA probe technique on a previously isolated and identified organism to categorize the organism more specifically, such as to the taxonomic… | 4 | 10 | 580 | $90 | $85.4K |
| 80053 | The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel. | 6 | 130 | 1,600 | $1 | $74.9K |
| 88305 | The physician, typically a pathologist, performs a level IV examination of a surgical pathology specimen. The examination includes accessioning the specimen into the lab, which involves formally… | 2 | 90 | 200 | $20 | $71.6K |
| 88185 | The lab analyst performs the technical component of a flow cytometry procedure using cell surface, cytoplasmic, or nuclear markers to characterize cells and aid clinicians in diagnosing patients with… | 4 | 10 | 130 | $100 | $71.2K |
Showing 1–10 of 162
Other providers in the same ZIP code as Laboratory Medicine Consultants Ltd, ranked by combined Medicare and Medicaid revenue.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.